Pharmaceuticals & Biotechnology

Meena L. Elliott

Meena Elliott is a C-suite executive with an expansive and deep breadth and depth of experience. As President of Kiverdi, Inc., she leads the organization to success with a laser focus on customer happiness and cash flow management, in addition to establishing the foundational strategy. Kiverdi, Inc. is a mid-stage … Read more

Connie R. Collingsworth

Connie Collingsworth is an experienced independent board member with expertise in governance, risk management, regulatory compliance, executive compensation, sustainability and complex investments. She has served as a board member and strategic advisor for publicly traded and privately held companies, private equity and venture capital funds, nonprofit corporations and trusts.
Connie … Read more

Linda L. Addison

Linda Addison is an experienced independent director and chief executive, currently building out her board portfolio with private and PE-backed
companies. She is Lead Independent Director of Globe Life Inc. (NYSE: GL), an S&P 500 company, and a board member of Lexitas, an Apax Partners
private equity portfolio company. She … Read more

Susan H. Alexander

Susan H. Alexander is Executive Vice President, Chief Legal Officer, and Corporate Secretary of Biogen. Biogen is a global Fortune 500 global biotechnology company focused on discovering, developing, and marketing therapies for the treatment of neurological disorders and other serious diseases. Ms. Alexander is a member of the executive team … Read more

Catharine Biggs Arrowood

Catharine Biggs Arrowood is Retired of Counsel at Parker Poe Adams & Bernstein LLP in Raleigh, North Carolina.

After graduating Phi Beta Kappa from Wake Forest University, Ms. Arrowood attended its School of Law and graduated in 1976. Ms. Arrowood spent a year in the Antitrust Division of the North … Read more

Roya Behnia

Roya Behnia is Executive Vice President, Chief Legal Officer and Corporate Affairs of JELD-WEN, Inc. (NYSE: JELD), a global building products company with over $4.7 billion in revenues and over 24,000 employees. She guides the company and its board in all complex and sensitive strategic matters, including CEO transition, transformational … Read more